Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

FORGET: a screening tool for dementia

October 6, 2022
Dr Vellingiri Raja Badrakalimuthu
There is an urgent need to make screening processes for dementia easier, less time-consuming and sensitive so that it can be used by healthcare professionals in primary care and acute medical hospitals. This article reviews FORGET, a screening tool for dementia in community out patients clinic and acute medical hospital assessments.

Atrial fibrillation and stroke: using technology to promote anticoagulant decisions

October 6, 2022
admin
Technology to date has been considered to be a driving force in developing many aspects of healthcare provision and point of access care. In atrial fibrillation it can now be used to help make key treatment decisions.

Greater parental knowledge of their child’s eczema results in improvements to their skin

October 6, 2022
admin
Children whose parents are actively involved in managing their eczema see greater results, a new survey commissioned by Epaderm and carried out in partnership with talkhealth has revealed.

June 2017 issue

October 6, 2022
admin
GM's June 2017 issue is out now, and all the articles from the print journal are also published online. Find out what's in this month's issue here.

Anti-epileptic drug receives positive EU opinion for monotherapy and adjunctive therapy

April 10, 2024
admin
The anti-epileptic drug (AED) lacosamide (VIMPAT) has received a positive opinion on a licence extension, meaning it can be used as monotherapy and adjunctive therapy in the treatment of focal-onset seizures (FOS) in children from 4-16 years of age.

Statins should be offered to everyone who has chronic kidney disease, says NICE

October 6, 2022
admin
Healthcare professionals should offer statins to millions of people with chronic kidney disease (CKD), as this will help them to manage the increased risk of cardiovascular disease (CVD), NICE has said.

Government’s air pollution plan a €œbig step forward€, says British Heart Foundation

October 6, 2022
admin
The government's plan to tackle air pollution has been hailed as a €œbig step forward€ by the British Heart Foundation, although they warned it's unlikely many of the people living in today's polluted streets will see many of the benefits.

NICE recommends treatment for severe COPD

October 6, 2022
admin
NICE has published a Technology Appraisal Guidance (TAG) recommending roflumilast for use within NHS England as an add-on option to treat adults with severe COPD who continue to experience exacerbations despite triple inhaled therapy.

Nutrition advice aimed at children also improves parents’ diet

April 10, 2024
admin
Nutrition advice aimed at children also improves parents' diets, according to research published in the European Journal of Preventive Cardiology.

GP waiting times set to soar by 2022 according to RCGP

October 6, 2022
admin
Patients across England face waiting longer than a week for a GP or practice nurse appointment on more than 100 million occasions by 2022,  the Royal College of General Practitioners has warned.

Why exhibit?

October 6, 2022
admin
Exhibiting at the GM Conference gives you the chance to meet professionals in primary and secondary care with an interest in 50+ healthcare. Find out more.

Programme

October 6, 2022
admin
Information about speaker sessions at the GM Conference 2019, The Ageing Patient: Midlife and Beyond. 

Age UK raises concerns as life expectancy set to stop increasing

October 6, 2022
admin
Age UK has urged for a debate into how we fund health and care after it was announced that England's average life expectancy rates are slowing dramatically.

Survival for UK cancer patients is lower than in much of Europe

October 6, 2022
admin
Survival for UK cancer patients is lower than in much of Europe, according to a new report.  

CHMP issues positive opinion for edoxaban in patients with AF undergoing cardioversion

October 6, 2022
admin
The European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of LIXIANA (edoxaban) in patients with atrial fibrillation (AF) undergoing cardioversion, pharmaceutical Daiichi Sankyo has announced.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy